Skip to content

PHARMACENTRE

Active
Public limited companyfounded 198739 yrs activeChaussée de Namur 5, 1300 Wavre, BelgiumKBO/BCE: BE 0431.307.134
Summary

PHARMACENTRE has been active since 1987 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €78,845 and a net result of €56,429. Equity remains stable across the filed fiscal years (±0.2% per year). Its solvency ranks better than 71% of 4238 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability100=
Solvency82▲+2
Growth52=
Track record100
Bankruptcy probability, 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €6,000 at 30 days acceptable
Liquidity ample (current ratio 2.31 against 2.2 in 2024; short-term debt: 43.2% and cash: 27.3% of total assets), and 43.2% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 39 years 0 40 y
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
56.8%
Return on assets
40.6%
Age of the figures
9 mo
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 11-06-2026, 50 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
50 d early
2024
59 d early
2023
57 d early
2022
59 d early
2021
58 d early
2020
61 d early
2019
57 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 57 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 3 June (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
30-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 4 June 1987, PHARMACENTRE was incorporated.1 Total assets went from EUR 296,855 in 2018 to EUR 138,900 in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018 and 2025

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, full schema

Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€56,429▲ 3.0%
2024 · €54,793
Working capital
€78,845▲ 1.8%
2024 · €77,417
Trend over the years
In euros
In per cent
Ratio
In full-time equivalents (FTE)
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
In full-time equivalents (FTE)
No line ticked in this group.

Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result€75,330▼ 1.1%€67,546▼ 10.3%€46,446▼ 31.2%€72,690▲ 56.5%€74,624▲ 2.7%
Net result€55,756within the sector's middle half▼ 7.3%€50,042above the sector's middle half▼ 10.2%€34,303within the sector's middle half▼ 31.5%€54,793within the sector's middle half▲ 59.7%€56,429within the sector's middle half▲ 3.0%
Equity€78,279within the sector's middle half▲ 7.9%€78,321within the sector's middle half▲ 0.1%€82,623within the sector's middle half▲ 5.5%€77,417within the sector's middle half▼ 6.3%€78,845below the sector's middle half▲ 1.8%
Total assets€128,279below the sector's middle half▼ 41.5%€145,703within the sector's middle half▲ 13.6%€114,093below the sector's middle half▼ 21.7%€141,827below the sector's middle half▲ 24.3%€138,900below the sector's middle half▼ 2.1%
Debt€50,000▼ 65.9%€67,383▲ 34.8%€31,470▼ 53.3%€64,410▲ 105%€60,055▼ 6.8%
Working capital€78,279within the sector's middle half▲ 7.9%€49,939within the sector's middle half▼ 36.2%€82,623within the sector's middle half▲ 65.4%€77,417within the sector's middle half▼ 6.3%€78,845within the sector's middle half▲ 1.8%
Solvency61.0%above the sector's middle half▲ 27.9pp53.8%within the sector's middle half▼ 7.3pp72.4%above the sector's middle half▲ 18.7pp54.6%within the sector's middle half▼ 17.8pp56.8%within the sector's middle half▲ 2.2pp
Current ratio2.57above the sector's middle half▲ 1.071.74within the sector's middle half▼ 0.823.63above the sector's middle half▲ 1.882.20within the sector's middle half▼ 1.422.31within the sector's middle half▲ 0.11
Return on assets (ROA)43.5%above the sector's middle half▲ 16.0pp34.3%above the sector's middle half▼ 9.1pp30.1%above the sector's middle half▼ 4.3pp38.6%above the sector's middle half▲ 8.6pp40.6%above the sector's middle half▲ 2.0pp
Staff (FTE)0below the sector's middle half0below the sector's middle half
above within below the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
€0€20,000€40,000€60,000€80,000Operating result 2021: €75,330€75,330Net result 2021: €55,756€55,756Operating result 2022: €67,546€67,546Net result 2022: €50,042€50,042Operating result 2023: €46,446€46,446Net result 2023: €34,303€34,303Operating result 2024: €72,690€72,690Net result 2024: €54,793€54,793Operating result 2025: €74,624€74,624Net result 2025: €56,429€56,42920212022202320242025€0€20,000€40,000€60,000€80,000Operating result 2023: €46,446€46,400Net result 2023: €34,303€34,300Operating result 2024: €72,690€72,700Net result 2024: €54,793€54,800Operating result 2025: €74,624€74,600Net result 2025: €56,429€56,400202320242025
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 3% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €138,900
Equity €78,845 ▲ 1.8%
Debt €60,055 ▼ 6.8%
Debt's share of the balance-sheet total falls from 45.4% to 43.2%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
Debt to equity
0.76▼
2024 · 0.83
ROE
71.6%▲
2024 · 70.8%
Debt ≤ 1 year
€60,055▼
2024 · €64,410
Income taxes
€18,558▲
2024 · €18,458
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 31,371 companies that looked in July 2024 the way this one looks now, 0.5% went bankrupt within 24 months and 93% are still going.

  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.5% went bankrupt
5.9% stopped otherwise
93% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 0.4% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,340 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 31,371 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 40 lines
Balance sheet Code20242025
Assets
Total assets20/58€141,827€138,900▼
Current assets29/58€141,827€138,900▼
Amounts receivable within one year40/41€1,011€100,998▲
Trade receivables40-€20
Other amounts receivable41€1,011€100,978▲
Cash at bank and in hand54/58€140,816€37,902▼
Equity and liabilities
Total equity and liabilities10/49€141,827€138,900▼
Equity10/15€77,417€78,845▲
Contributions10/11€62,000€62,000=
Capital10€62,000€62,000=
Issued capital100€62,000€62,000=
Reserves13€6,200€6,200=
Non-distributable reserves130/1€6,200€6,200=
Legal reserve130€6,200€6,200=
Profit (loss) carried forward14€9,217€10,645▲
Amounts payable17/49€64,410€60,055▼
Amounts payable within one year42/48€64,410€60,055▼
Taxes, remuneration and social security45€4,410€5,055▲
Taxes450/3€4,410€5,055▲
Other amounts payable47/48€60,000€55,000▼
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€0-
Other operating charges640/8€457€445▼
Non-recurring operating charges66A€0-
Gross operating margin9900€73,147€75,069▲
Operating profit (loss)9901€72,690€74,624▲
Financial income75/76B€1,011€979▼
Recurring financial income75€1,011€979▼
Financial charges65/66B€450€617▲
Recurring financial charges65€450€617▲
Profit (loss) for the period before taxes9903€73,251€74,986▲
Income taxes67/77€18,458€18,558▲
Profit (loss) for the period9904€54,793€56,429▲
Profit (loss) for the period to be appropriated9905€54,793€56,429▲
Appropriation of the result
Profit (loss) to be appropriated9906€69,217€65,645▼
Profit (loss) brought forward from the previous period14P€14,423€9,217▼
Transfer to equity691/2€0-
To the legal reserve6920€0-
Profit to be distributed694/7€60,000€55,000▼
Return on contributions (dividend)694€60,000€55,000▼
Social balance
Average headcount (FTE)90870.0-
Line20212022202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630-€1,618€2,250€0--
Other operating charges640/8€348€348€384€457€445▼ 2.8%
Non-recurring operating charges66A--€26,131€0--
Gross operating margin9900€75,677€69,512€75,211€73,147€75,069▲ 2.6%
Operating profit (loss)9901€75,330€67,546€46,446€72,690€74,624▲ 2.7%
Financial income75/76B€0€0€0€1,011€979▼ 3.2%
Recurring financial income75€0€0€0€1,011€979▼ 3.2%
Financial charges65/66B€619€626€615€450€617▲ 37.1%
Recurring financial charges65€619€626€615€450€617▲ 37.1%
Profit (loss) for the period before taxes9903€74,711€66,919€45,832€73,251€74,986▲ 2.4%
Income taxes67/77€18,955€16,878€11,529€18,458€18,558▲ 0.5%
Profit (loss) for the period9904€55,756€50,042€34,303€54,793€56,429▲ 3.0%
Profit (loss) for the period to be appropriated9905€55,756€50,042€34,303€54,793€56,429▲ 3.0%
Line20212022202320242025Change
Assets
Total assets20/58€128,279€145,703€114,093€141,827€138,900▼ 2.1%
Fixed assets21/28-€28,382€0---
Intangible fixed assets21-€28,382€0---
Current assets29/58€128,279€117,322€114,093€141,827€138,900▼ 2.1%
Amounts receivable within one year40/41€0-€6,500€1,011€100,998▲ 9,890%
Trade receivables40----€20-
Other amounts receivable41€0-€6,500€1,011€100,978▲ 9,888%
Cash at bank and in hand54/58€128,279€117,322€107,593€140,816€37,902▼ 73.1%
Equity and liabilities
Total equity and liabilities10/49€128,279€145,703€114,093€141,827€138,900▼ 2.1%
Equity10/15€78,279€78,321€82,623€77,417€78,845▲ 1.8%
Contributions10/11€62,000€62,000€62,000€62,000€62,000=
Capital10€62,000€62,000€62,000€62,000€62,000=
Issued capital100€62,000€62,000€62,000€62,000€62,000=
Reserves13€6,200€6,200€6,200€6,200€6,200=
Non-distributable reserves130/1€6,200€6,200€6,200€6,200€6,200=
Legal reserve130€6,200€6,200€6,200€6,200€6,200=
Profit (loss) carried forward14€10,079€10,121€14,423€9,217€10,645▲ 15.5%
Amounts payable17/49€50,000€67,383€31,470€64,410€60,055▼ 6.8%
Amounts payable within one year42/48€50,000€67,383€31,470€64,410€60,055▼ 6.8%
Trade debts44-€5,713€0---
Suppliers440/4-€5,713€0---
Taxes, remuneration and social security45€0€11,670€1,470€4,410€5,055▲ 14.6%
Taxes450/3€0€11,670€1,470€4,410€5,055▲ 14.6%
Other amounts payable47/48€50,000€50,000€30,000€60,000€55,000▼ 8.3%
Line20212022202320242025Change
Profit (loss) for the period9904€55,756€50,042€34,303€54,793€56,429▲ 3.0%
+ Depreciation and write-downs630-€1,618€2,250€0--
Operating cash flow (approximation)€55,756€51,660€36,553€54,793€56,429▲ 3.0%
Investment in fixed assets (approximation)--€26,132---
Change in cash--€10,957-€9,728€33,222-€102,913▼ 410%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
11-06
NBB filing Annual accounts filed
fiscal year 2025 · full schema
2025
02-06
NBB filing Annual accounts filed
fiscal year 2024 · full schema
2024
04-06
NBB filing Annual accounts filed
fiscal year 2023 · full schema
2023
31-12
Financial Weakest financial yearnet €34,303 ▼31.5%
Net result drops to €34,303, the lowest in the series; recovery starts the following year.
31-12
Financial Liquidity doublescurrent ratio 3.63
Current ratio from 1.74 to 3.63; short-term debt falls from €67,383 to €31,470.
02-06
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
03-06
NBB filing Annual accounts filed
fiscal year 2021 · full schema
2021
31-05
NBB filing Annual accounts filed
fiscal year 2020 · full schema
2020
31-12
Financial Highest result since 2018net €60,169 ▲8.4%
Net result €60,169, the highest in the series.
04-06
NBB filing Annual accounts filed
fiscal year 2019 · full schema
2019
31-12
Financial Liquidity quadruplescurrent ratio 5.13
Current ratio from 1.35 to 5.13; short-term debt falls from €220,000 to €32,050.
31-12
Financial Equity above €100,000Eq €132,354 ▲72.2%
2 profitable years in a row build equity to €132,354.
Show earlier events
02-07
NBB filing Annual accounts filed
fiscal year 2018 · full schema
2018
21-06
NBB filing Annual accounts filed
fiscal year 2017 · full schema
2017
20-07
NBB filing Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 9 acts read
About the unread acts

We know of 9 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
9 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Wavre · 1 establishment unit since 1987
seat establishment The establishment unit on the map
Ground area
1,141 m²
Building footprint
261 m²
Volume, LiDAR
2,521 m³
2 parcels, Wallonia · tallest building 13.0 m, ±3 floors. Linked by address, not a title deed.
5 companies at this address See who is registered here
1 establishment unit
PHARMACENTRE
Chaussée de Bruxelles 183, 1410 WaterlooWarehousing and support activities for transportation
since 19872.030.651.547
2 parcels
Wallonia 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
25112L0283/00V002 Wallonia 863 m² 1 · 206 m² 13.0 m · 3 fl.
25763L0382/00B000 Wallonia 278 m² 1 · 55 m² 10.9 m · 3 fl.
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Structure & network

Owners and holdings

1 owner

Chain of control

  1. PHARMACIES SERVAIS 100%
  2. PHARMACENTRE

Highest known parent: PHARMACIES SERVAIS. The sources do not say who stands above it.

Owners 1

Holdings 0

The accounts to 31-12-2025 list no holdings, and no other source names one.

According to the 2025 annual accounts of PHARMACENTRE and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

No current directors or connected companies found in the register.

Recognitions · licences · registrations

Food safety, FASFC

1 site
Waterloo2.030.651.547
1 permission
Apotheek (LM>3 maand) · since 01-01-2006

Similar companies · same sector, comparable size

Of 5,220 companies in sector 47730 we hold annual accounts for 3,862. 3,229 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPublic limited company
Founded04-06-1987
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Contact
E-mail es@pharmacieservais.be
E-invoicing
Reachable via Peppol
Peppol ID 0208:0431307134
Registered 27-03-2026

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 30 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.